Free Trial
Allen Klee

Allen Klee Analyst Performance

Managing Director, Senior Research Analyst at Maxim Group

Allen Klee is a stock analyst at Maxim Group across a range of sectors, covering 49 publicly traded companies. Over the past year, Allen Klee has issued 16 stock ratings, including strong buy, buy, and hold recommendations. While full access to Allen Klee's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Allen Klee's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
161 Last 8 Years
Buy Recommendations
91.19% 145 Buy Ratings
Companies Covered
49 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy1.3%2 ratings
Buy89.9%143 ratings
Hold8.8%13 ratings
Sell0.0%0 ratings

Out of 159 total stock ratings issued by Allen Klee at Maxim Group, the majority (89.9%) have been Buy recommendations, followed by 8.8% Hold and 1.3% Strong Buy.

Exchange Coverage

ExchangePercentageCount
NASDAQ
83.7% of companies on NASDAQ
41 companies
NYSEAMERICAN
10.2% of companies on NYSEAMERICAN
5 companies
OTC
2.0% of companies on OTC
1 company
OTCMKTS
2.0% of companies on OTCMKTS
1 company
NYSE
2.0% of companies on NYSE
1 company

Allen Klee, an analyst at Maxim Group, currently covers 49 companies listed on NASDAQ, NYSEAMERICAN, OTC, OTCMKTS and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Computer and Technology
20 companies
40.8%
Business Services
11 companies
22.4%
Medical
4 companies
8.2%
Retail/Wholesale
4 companies
8.2%
Industrials
3 companies
6.1%
Finance
2 companies
4.1%
Consumer Discretionary
2 companies
4.1%
Multi-Sector Conglomerates
1 company
2.0%
Transportation
1 company
2.0%
Aerospace
1 company
2.0%

Allen Klee of Maxim Group specializes in stock coverage within the Computer and Technology sector, with additional focus on Business Services and Medical companies.

Coverage Industries

IndustryPercentage
TECHNOLOGY SERVICES
9 companies
18.4%
INTERNET SOFTWARE
4 companies
8.2%
COMP - SERVICES
2 companies
4.1%
CUSTOM COMPUTER PROGRAMMING SERVICES
2 companies
4.1%
DATA PROCESSING & PREPARATION
2 companies
4.1%
CATALOG & MAIL - ORDER HOUSES
2 companies
4.1%
BUSINESS SERVICES
2 companies
4.1%
COMPUTER INTEGRATED SYSTEMS DESIGN
2 companies
4.1%
IT SERVICES
1 company
2.0%
DIVERSIFIED OPS
1 company
2.0%
INSURANCE AGENTS, BROKERS & SERVICE
1 company
2.0%
INS - BROKERS
1 company
2.0%
MEDICAL SERVICES
1 company
2.0%
COMP - OPTICL REC
1 company
2.0%
LEISURE&REC SVS
1 company
2.0%
INTERNET CONTENT
1 company
2.0%
MEDICAL CARE FACILITIES
1 company
2.0%
BUSINESS SERVICES, NOT ELSEWHERE CLASSIFIED
1 company
2.0%
PRINTING - COMMRL
1 company
2.0%
PROTECTION - SFTY
1 company
2.0%
MEDICAL INFO SYS
1 company
2.0%
PREPACKAGED SOFTWARE
1 company
2.0%
COMP - INTEGT SYS
1 company
2.0%
WIRELESS NATIONAL
1 company
2.0%
INTERNET COMMERCE
1 company
2.0%
AUDIO/VIDEO PRD
1 company
2.0%
AUTOMOTIVE RENTAL & LEASING, WITHOUT DRIVERS
1 company
2.0%
FUNCTIONS RELATED TO DEPOSITORY BANKING
1 company
2.0%
OFFICE AUTO&EQP
1 company
2.0%
ELEC - MILITARY
1 company
2.0%
INTERNET SERVICES
1 company
2.0%
COMMUNICATION SERVICES
1 company
2.0%

About Allen Klee

Allen Klee is Managing Director, Senior Equity Research Analyst at Maxim Group LLC covering tech, telecom, media, and healthcare technology. Prior to joining Maxim, Mr. Klee was a Managing Director, Equity Analyst covering TMT at National Securities Corporation. Prior sell-side experience includes working at Maxim Group as an SVP of Equity Research and Sidoti & Company, LLC as a Senior Equity Analyst also covering TMT. Other experience includes buy-side roles as a Prop Trader at Xanthus Capital, Equity Analyst at both Casey Capital and Sigma Capital, and as a Portfolio Manager for small and midcap mutual funds at both First Investors Corporation and Guardian Life Insurance. Prior to that, Mr. Klee was a Senior Credit Analyst at both Guardian Life Insurance and at Moody’s Investor Service. Mr. Klee earned his MBA in Finance from the NYU Stern School of Business and has a B.S. from Rutgers University with a double major in BioMathematics and Economics. He also holds the CFA designation.
Follow on LinkedIn

Allen Klee's Ratings History at Maxim Group

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
T Stamp Inc. stock logo
IDAI
T Stamp
9/19/2025Boost Price Target$2.89$12.00Buy
Jet.AI Inc. stock logo
JTAI
Jet.AI
8/20/2025Lower Price Target$3.04$11.00Buy
reAlpha Tech Corp. stock logo
AIRE
reAlpha Tech
7/28/2025Reiterated Rating$0.42Hold
Health In Tech, Inc. stock logo
HIT
Health In Tech
6/26/2025Upgrade$0.76$2.50Strong-Buy
Ohmyhome Limited stock logo
OMH
Ohmyhome
6/16/2025Downgrade$1.42Hold
ARB IOT Group Limited stock logo
ARBB
ARB IOT Group
6/9/2025Upgrade$5.73$20.00Strong-Buy
DeFi Technologies Inc. stock logo
DEFT
DeFi Technologies
5/27/2025Boost Price Target$3.72$7.00Buy
reAlpha Tech Corp. stock logo
AIRE
reAlpha Tech
5/21/2025Lower Price Target$0.53$1.25Buy
Oxbridge Re Holdings Limited stock logo
OXBR
Oxbridge Re
4/30/2025Initiated Coverage$1.33$5.00Buy
Castellum, Inc. stock logo
CTM
Castellum
4/24/2025Set Price Target$0.99$3.00Buy
Cryo-Cell International Inc. stock logo
CCEL
Cryo-Cell International
3/4/2025Lower Price Target$6.60$8.50Buy
VSee Health, Inc. stock logo
VSEE
VSee Health
2/24/2025Initiated Coverage$1.82$5.00Buy
Innodata Inc. stock logo
INOD
Innodata
2/21/2025Boost Price Target$62.45$75.00Buy
Mitek Systems, Inc. stock logo
MITK
Mitek Systems
2/11/2025Boost Price Target$9.91$14.00Buy
Giftify, Inc. stock logo
GIFT
Giftify
2/5/2025Initiated Coverage$1.11$4.00Buy
Orangekloud Technology Inc. stock logo
ORKT
Orangekloud Technology
1/30/2025Initiated Coverage$5.48$20.00Buy